Kevin M. Henry

Kevin Henry assists the firm in patent prosecution in the pharmaceutical, biotechnology, and chemical industries.

Representative Matters

Supply technical expertise to investors as part of due diligence on prospective acquisitions.
Provide prior art searching and patentability analysis to clients in the biotechnology and pharmaceutical industries.
Work with research scientists in reviewing invention disclosures.

Previous Experience

Before joining the firm, Kevin was a medicinal chemist with Encysive Pharmaceuticals (acquired by Pfizer), where he developed small molecule antagonists of G-protein coupled receptors.

Kevin also worked in the oil and gas industry as a senior chemist with Nalco Energy Services. There he provided technical and logistical support for the pipeline integrity program at British Petroleum’s (BP) oilfields in Prudhoe Bay, Alaska.

Kevin’s doctoral work focused on key aspects of aflatoxin biosynthesis in Aspergillus fungi.

Professional and Civic Activities

American Chemical Society

Also Noteworthy

Kevin is a co-inventor on several pending patents in the oil and pharmaceutical industries.

Education

University of Massachusetts at Amherst, B.A., English

Johns Hopkins University, Ph.D., Chemistry

Suffolk University Law School, J.D., 2012 Candidate

Admitted To Practice

U.S. Patent and Trademark Office